المؤلفون: Tombal, Bertrand F., Remacle, Christine, Vubu, Monique Kasa

المساهمون: UCL - (SLuc) Centre du cancer, UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Centre de pathologie sexuelle masculine, UCL - (SLuc) Service d'urologie

مصطلحات موضوعية: Prostate cancer, Renal cell carcinoma, Androgen deprivation therapy, Tyrosine kinase inhibitors, mTOR inhibitors, Side effects

العلاقة: boreal:263964; http://hdl.handle.net/2078.1/263964Test; urn:ISBN:978-3-319-70252-0

الإتاحة: https://doi.org/10.1007/978-3-319-70253-7_6Test
http://hdl.handle.net/2078.1/263964Test

المؤلفون: Tombal, Bertrand F., Remacle, Christine, Vubu, Monique Kasa

المساهمون: UCL - (SLuc) Centre du cancer, UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Centre de pathologie sexuelle masculine, UCL - (SLuc) Service d'urologie

مصطلحات موضوعية: Prostate cancer, Renal cell carcinoma, Androgen deprivation therapy, Tyrosine kinase inhibitors, mTOR inhibitors, Side effects

العلاقة: boreal:263964; http://hdl.handle.net/2078.1/263964Test; urn:ISBN:978-3-319-70252-0

الإتاحة: https://doi.org/10.1007/978-3-319-70253-7_6Test
http://hdl.handle.net/2078.1/263964Test